Results

Total Results: 114 records

Showing results for "statin".
Users also searched for: statin

81. Final Progress Report: Dissemination of the PPRNet Model for Improving Medication Safety (pdf file)
    www.ahrq.gov/sites/default/files/2024-01/wessell-report.pdf
    January 01, 2024 - Drug-Drug Interactions • Macrolide antibiotics and digoxin • Tetracycline and digoxin • Itraconazole and statin

82. Final Progress Report: Medication Safety in Primary Care Practice Translating Research Into Practice (MS-TRIP) (pdf file)
    www.ahrq.gov/sites/default/files/2024-02/ornstein-report.pdf
    January 01, 2024 - • Avoidance of itraconazole and statin. 5 • Avoidance of lithium and thiazide.

83. Preparing for Ambulatory Computerized Prescriber Order Entry by Evaluating Preimplementation Medication Errors (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol2/Devine.pdf
    July 01, 2003 - prior to instituting therapy with hydroxymethyl-glutaryl coenzyme A (HMG-CoA) reductase inhibitor (statin … included in the Laboratory Harm Table, whereas the ongoing monitoring of a lipid panel to assess statin

84. Improving Healthcare Safety by Enhancing Medication Safety (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/highlights/ps-project-highlights-medication-safety.pdf
    April 30, 2025 - - 3A4 substrate versus a statin non-3A4 substrate with CYP3A4 inhibitor concomitancy. … evaluate the nonsignificant yet increased muscle toxicity interaction ratio observed for highly potent statin … dosages and within 6 months after statin initiation. … However, the overall results show no evidence of increased hazard of statin- related adverse events based … on statin metabolism.

85. Federal Interagency Workgroup: Improving Diagnostic Safety and Quality in Healthcare: March 2024 Meeting (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/topics/dx-safety-workgroup-meeting-notes-mar2024.pdf
    July 26, 2024 - Federal Interagency Workgroup: Improving Diagnostic Safety and Quality in Healthcare: March 2024 Meeting Federal Interagency Workgroup: Improving Diagnostic Safety and Quality in Healthcare March 2024 Meeting Workgroup Goal: Established by Senate Report 115-150. The Senate Committee on Appropriations request…

86. EvidenceNow Practice Survey Codebook: Practice Demographics (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/results/research/survey-codebook-demographics.pdf
    June 02, 2025 - practice uses clinical guidelines for management of patients at risk for cardiovascular disease (e.g., statin

87. Section 8: The Care Management Evidence Base | Agency for Healthcare Research and Quality
    www.ahrq.gov/patient-safety/settings/long-term-care/resource/hcbs/medicaidmgmt/mm8.html
    October 01, 2014 - Designing and Implementing Medicaid Disease and Care Management Programs Section 8: The Care Management Evidence Base Previous Page Next Page Table of Contents Designing and Implementing Medicaid Disease and Care Management Programs Introduction Section 1: Planning a Care Management Program Se…

88. Practice Characteristic survey baseline NC Cooperative (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/results/research/practice-survey-nc.pdf
    November 14, 2015 - clinical guidelines for management of patients at risk for cardiovascular disease prevention (e.g., statin

89. Final progress Report: Anticholinergics and Cognitive Decline in the Elderly with Depression (pdf file)
    www.ahrq.gov/sites/default/files/2024-01/aparasu-report.pdf
    January 01, 2024 - Final progress Report: Anticholinergics and Cognitive Decline in the Elderly with Depression FINAL PROGRESS REPORT ANTICHOLINERGICS AND COGNITIVE DECLINE IN THE ELDERLY WITH DEPRESSION TITLE: Anticholinergics and Cognitive Decline in the Elderly with Depression PRINICIPAL INVESTIGATOR: Aparasu, Rajender R.1 TEAM…

90. Scoring CPCQ (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/results/research/cpcq-scoring.pdf
    May 01, 2017 - Scoring CPCQ 1 Scoring the Change Process Capability Questionnaire Strategies Items: Current Plan National Evaluation Team May 1, 2017 2 Introduction The RFA from AHRQ for EvidenceNOW: http://grants.nih.gov/grants/guide/rfa-files/RFA-HS-14-008.html described the required measures of practice…

91. Nutritional Research Series - Volume 4: Effects of Eicosapentanoic Acid and Docosahexanoic Acid on Mortality Across Diverse Settings: Systematic Review and Meta-Analysis of Randomized Trials and Prospective Cohorts (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/research/findings/evidence-based-reports/nutrtp4.pdf
    February 01, 2012 - Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with

92. Impact of Pharmacy-led Dyslipidemia Interventions on Medication Safety and Therapeutic Failure in Patients (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/Weaver.pdf
    January 01, 2003 - Since FDA labeling changes for unsafe combination regimens with simvastatin, the DoD’s preferred statin

93. Final Progress Report: Trial of Decision Support To Improve Diabetes Outcomes (pdf file)
    www.ahrq.gov/sites/default/files/2024-07/cebul-report.pdf
    January 01, 2024 - Final Progress Report: Trial of Decision Support To Improve Diabetes Outcomes Trial of Decision Support to Improve Diabetes Outcomes Randall D. Cebul, MD, PI, MetroHealth Medical System Neal V. Dawson, MD, Investigator Douglas Einstadter, MD, Investigator Peter Greco, MD, Investigator Thomas Love, PhD, Investi…

94. Meeting Minutes, July 2017 | Agency for Healthcare Research and Quality
    www.ahrq.gov/news/events/nac/2017-07-nac/nacmtg0717-minutes.html
    November 01, 2017 - Preventive Services Task Force produced final new recommendations for statin use for the primary prevention

95. Apcd-Inventory (xls file)
    www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/quality-resources/apcd/apcd-inventory.xlsx
    October 01, 2015 - No Cardiac Coronary artery disease (CAD) Quality Process Adherence to Statin Therapy for Individuals … No Diabetes Not applicable Quality Process Diabetes Care: Statin Use (patients ages 40 through 75 or

96. Case Example #4: Foresight Family Physicians | Agency for Healthcare Research and Quality
    www.ahrq.gov/ncepcr/tools/workforce-financing/case-example-4.html
    July 01, 2019 - site visit addressed workflow mapping for implementing the PAM and determining workflow for assuring statin

97. New Models of Primary Care Workforce and Financing - Case Example #4: Foresight Family Physicians (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/primary-care/workforce-financing/case_example_4.pdf
    October 01, 2016 - site visit addressed workflow mapping for implementing the PAM and determining workflow for assuring statin

98. Final Report: Improving Drug Safety (pdf file)
    www.ahrq.gov/sites/default/files/2024-01/magid-report.pdf
    January 01, 2024 - monitoring recommendations has only been conducted for selected drugs, such as liver function testing for statin

99. 0129Table8 (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/0129table8.pdf
    January 01, 2013 - Table 8 – Evidence for the Relationship between Readmission and Quality of Care Type of Evidence Key Findings Citation Readmission and Quality of Care Coordination, Discharge, and Care Transition Processes Meta-analysis Investigators reviewed randomized controlled studies of structured telephone support or t…

100. Development of a Computerized Adverse Drug Event (ADE) Monitor in the Outpatient Setting (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol2/Seger.pdf
     January 01, 2003 - Development of a Computerized Adverse Drug Event (ADE) Monitor in the Outpatient Setting 173 Development of a Computerized Adverse Drug Event (ADE) Monitor in the Outpatient Setting Andrew C. Seger, Tejal K. Gandhi, Carol Hope, J. Marc Overhage, Michael D. Murray, David Weber, Julie Fiskio, Evgenia Teal,…